Clinical Study Demonstrates Positive Effects
CHANNAHON, Ill., June 4, 2003 – Clarinol™ CLA, a leading brand of conjugated linoleic acid (CLA) enabled study subjects to increase weight reduction and feel better during weight loss , according to research underwritten by Loders Croklaan Lipid Nutrition.
In a double-blind, placebo controlled study, conducted at the University of Wisconsin Beers-Murphy Clinical Nutrition Center, study subjects who received 6 grams of Clarinol CLA or a placebo a day lost a significant amount of body fat during a 12 week period on a very low calorie diet. The group taking Clarinol CLA had a significant decrease in adverse effects typically associated with low calorie diets compared with those in the control group.
“Dieting is challenging for a lot of people, especially those who have unrealistic expectations about how long it will take to lose weight. Additionally, low calorie diets, themselves, can negatively affect people both psychologically and physically,” said Katinka Abbenbroek, marketing director for Loders Croklaan. “This study indicates that Clarinol CLA helps people address some of those issues and feel better while they lose weight.”
The study involved sixty obese men and women, who were randomly assigned to either the treatment or control group, and were on a low-calorie diet. At the conclusion of the 28-week trial (consisting of a 12-week weight loss period and 16 week weight regain period):
o The Clarinol CLA group lost more weight overall and regained more lean body mass
o Females in the Clarinol CLA group lost more total weight and more fat weight
Additionally, those in the Clarinol CLA group reported significantly fewer occurrences of the adverse side effects typically associated with dieting, such as skin rash, irritability, anger, depression and hair loss. The weight loss process, overall, was more pleasant and easier to sustain for the Clarinol CLA group. Safety analyses, including metabolic variables, liver and renal function, did not differ, thus Clarinol CLA was found to be safe.
Results from this ongoing research program have been presented at the Federation of American Societies for Experimental Biology (FASEB), American Oil Chemist Society (AOCS) and Vitafoods 2003. Publication of the results in a peer-reviewed journal is pending.
Headquartered in Wormerveer, The Netherlands, the company has manufacturing facilities around the world and is ISO 9001 and ISO 14001 certified. More information about Loders Croklaan Lipid Nutrition and its products can be found on the Internet at www.lipidnutrition.com.
# # #
Business Contact: Marianne O’Shea, Ph.D.